CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Jun 27, 2016
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options(Right to Buy)
2016-06-24+86,486→ 86,486 totalExercise: $1.15From: 2016-06-24Exp: 2026-06-24→ Common Stock (86,486 underlying)